Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development
- 3 January 2022
- journal article
- review article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 434 (6) , 167438
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI134732)
- National Natural Science Foundation of China (81772173, 81971916)
- National Science and Technology Major Project (2018ZX10301-408-002)
This publication has 228 references indexed in Scilit:
- The Transcription Factor STAT-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral ResponseImmunity, 2013
- Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver PathologyCell Host & Microbe, 2012
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5Nature Immunology, 2011
- 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family membersNature, 2010
- Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3Nature Chemical Biology, 2010
- Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin EctodomainCell Host & Microbe, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 StrainsCell Host & Microbe, 2009
- Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cellsBiochemical and Biophysical Research Communications, 2008